diazan has been researched along with Leukemia L 1210 in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Demidova, NS; Fomina, MM; Goncharova, SA; Minenkova, EA | 1 |
| Goncharova, SA; Konovalova, NP; Shevtsova, VN | 2 |
| Goncharova, SA; Konovalova, NP; Shevtsova, BN | 1 |
| Djachkovskaya, RF; Emanuel, NM; Konovalova, NP | 1 |
| Demidova, NS; Goncharova, SA; Konovalova, NP; Shevtsova, VN | 1 |
6 other study(ies) available for diazan and Leukemia L 1210
| Article | Year |
|---|---|
[Cytogenetic characteristics of the leukemia L1210 strain in the development of drug resistance].
Topics: Animals; Antineoplastic Agents; Diazonium Compounds; Drug Resistance; Karyotyping; Leukemia L1210; Mice; Neoplasm Transplantation; Ploidies; Time Factors | 1984 |
[Effect of diazane on the mitotic cycle of transplantable leukemia LA in mice].
Topics: Animals; Azo Compounds; Cell Cycle; Depression, Chemical; Diazonium Compounds; DNA, Neoplasm; Leukemia L1210; Mice; Mitosis; Succinates | 1980 |
[Diazane resistance of leukemia L1210 strain: obtaining and kinetic characteristics of growth].
Topics: Animals; Diazonium Compounds; Drug Resistance; Kinetics; Leukemia L1210; Mice; Mice, Inbred Strains; Succinates | 1980 |
Antitumor activity of 1,2-bis diazoacetyl ethane.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Azo Compounds; Carcinoma, Hepatocellular; Diazonium Compounds; Drug Evaluation, Preclinical; Lethal Dose 50; Leukemia L1210; Leukocyte Count; Liver Neoplasms; Melanoma; Mice; Neoplasms, Experimental; Rats; Spleen; Succinates | 1976 |
[Influence of diazan on the mitotic cycle of leukemia L1210 cells].
Topics: Animals; Antineoplastic Agents; Azo Compounds; Diazonium Compounds; DNA; Drug Evaluation, Preclinical; Leukemia L1210; Leukocytes; Mice; Mitosis; Succinates; Time Factors | 1976 |
[Changes in the chemotherapy sensitivity of leukemia L1210 cells during the development of diazan resistance].
Topics: Animals; Antineoplastic Agents; Diazonium Compounds; Drug Evaluation, Preclinical; Drug Resistance; Leukemia L1210; Mice | 1985 |